Company: SCLXW
Filing Date: 2025-05-07
Form Type: POS AM
Source: 0001193125-25-115088
Chunk: 407

Company: Scilex Holding Co
Filing Date: 2025-05-07
Form: POS AM
Chunk 407
---
 This prospectus relates to the offer and sale from time to time by the Selling Stockholder of up to an aggregate of 6,685,714 Resale Shares, consisting of (i) up to 6,500,000 Penny Warrant Shares and (ii) up to 185,714 Issued Shares. For additional information regarding the issuances of Penny Warrants, see the section titled “ Certain Relationships and Related Party Transactions” above. We are registering the shares of Common Stock in order to permit the Selling Stockholder to offer the Resale Shares for resale from time to time. Except for the relationships described in the section titled “ Certain Relationships and Related Party Transactions” the Selling Stockholder has not had any material relationship with us within the past three years. The table below lists the Selling Stockholder and other information regarding the beneficial ownership of the shares of Common Stock by the Selling Stockholder. The second column lists the number of shares of Common Stock beneficially owned by the Selling Stockholder, based on its ownership of the Penny Warrants, as of March 31, 2025, that are currently exercisable or that will become exercisable by the Selling Stockholder within 60 days of March 31, 2025 without regard to any limitations on exercises. The beneficial ownership of Common Stock is based on 6,951,671 shares of such Common Stock outstanding as of March 31, 2025. Voting power is based on 6,951,671 shares of Common Stock and 29,057,097 shares of Series A Preferred Stock outstanding as of March 31, 2025, with the Series A Preferred Stock entitled to an aggregate of 922,447 votes as a result of adjustments to the deemed conversion price of such preferred stock in accordance with the terms of the Series A Certificate of Designations. Shares of Series A Preferred Stock are held solely by SCLX JV. The third column lists the shares of Common Stock being offered by this prospectus by the Selling Stockholder. In accordance with the terms of the Oramed RRA with the Selling Stockholder, this prospectus generally covers the resale of the sum of the maximum number of shares of Common Stock issuable upon the exercise of the Penny Warrants, determined as if the outstanding Penny Warrants were exercised, as applicable, in full as of the trading day immediately preceding the date the registration statement of which this prospectus forms a part was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination